All In Biotech

Drug Trial Radar · NCT07446439

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

The Thetis Study: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight or Obese Volunteers

Last checked: Nov 19, 2026Latest source record: Apr 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

280

Planned (sponsor's estimate)

Start

Mar 27, 2026

Primary completion

Dec 1, 2026

Study completion Dec 1, 2026

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment arms.

Conditions

  • Nausea and Vomiting
  • Obesity

Interventions

  • TradipitantDrug

    Oral Capsule

  • PlaceboDrug

    Oral Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with at least 1 vomiting episode per week in the tradipitant group compared to the placebo group as measured by a daily symptom diary.Time frame: 1 week

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Los Angeles, California · Recruiting

  • Vanda Investigational Site

    San Diego, California · Recruiting

  • Vanda Investigational Site

    San Jose, California · Not yet recruiting

  • Vanda Investigational Site

    Tampa, Florida · Recruiting

  • Vanda Investigational Site

    Hamilton, New Jersey · Not yet recruiting

  • Vanda Investigational Site

    New York, New York · Not yet recruiting

  • Vanda Investigational Site

    Syosset, New York · Not yet recruiting

  • Vanda Investigational Site

    Plano, Texas · Not yet recruiting

  • Vanda Investigational Site

    San Antonio, Texas · Not yet recruiting

  • Vanda Investigational Site

    Burke, Virginia · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.